These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 28399515)
1. Healthcare professionals' views of the use and administration of two salvage therapy drugs for acute ulcerative colitis: a nested qualitative study within the CONSTRUCT trial. Clement C; Rapport F; Seagrove A; Alrubaiy L; Williams J BMJ Open; 2017 Feb; 7(2):e014512. PubMed ID: 28399515 [TBL] [Abstract][Full Text] [Related]
2. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT). Williams JG; Alam MF; Alrubaiy L; Clement C; Cohen D; Grey M; Hilton M; Hutchings HA; Longo M; Morgan JM; Rapport FL; Seagrove AC; Watkins A Health Technol Assess; 2016 Jun; 20(44):1-320. PubMed ID: 27329657 [TBL] [Abstract][Full Text] [Related]
3. Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT). Seagrove AC; Alam MF; Alrubaiy L; Cheung WY; Clement C; Cohen D; Grey M; Hilton M; Hutchings H; Morgan J; Rapport F; Roberts SE; Russell D; Russell I; Thomas L; Thorne K; Watkins A; Williams JG BMJ Open; 2014 Apr; 4(4):e005091. PubMed ID: 24785401 [TBL] [Abstract][Full Text] [Related]
4. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Williams JG; Alam MF; Alrubaiy L; Arnott I; Clement C; Cohen D; Gordon JN; Hawthorne AB; Hilton M; Hutchings HA; Jawhari AU; Longo M; Mansfield J; Morgan JM; Rapport F; Seagrove AC; Sebastian S; Shaw I; Travis SP; Watkins A Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):15-24. PubMed ID: 27595142 [TBL] [Abstract][Full Text] [Related]
5. Patient views about the impact of ulcerative colitis and its management with drug treatment and surgery: a nested qualitative study within the CONSTRUCT trial. Rapport F; Clement C; Seagrove AC; Alrubaiy L; Hutchings HA; Williams JG BMC Gastroenterol; 2019 Oct; 19(1):166. PubMed ID: 31615445 [TBL] [Abstract][Full Text] [Related]
6. Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study. Coates E; Wickramasekera N; Barr A; Shackley P; Lee M; Hind D; Probert C; Sebastian S; Totton N; Blackwell S; Bedford H; Dames N; Lobo A Health Technol Assess; 2022 Oct; 26(41):1-118. PubMed ID: 36305390 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab. Croft A; Walsh A; Doecke J; Cooley R; Howlett M; Radford-Smith G Aliment Pharmacol Ther; 2013 Aug; 38(3):294-302. PubMed ID: 23786158 [TBL] [Abstract][Full Text] [Related]
8. Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial. Alam MF; Longo M; Cohen D; Groves S; Alrubaiy L; Hutchings HA; Watkins A; Sebastain S; Williams JG BMC Health Serv Res; 2023 Mar; 23(1):226. PubMed ID: 36890533 [TBL] [Abstract][Full Text] [Related]
9. Review article: the practical management of acute severe ulcerative colitis. Seah D; De Cruz P Aliment Pharmacol Ther; 2016 Feb; 43(4):482-513. PubMed ID: 26725569 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Maser EA; Deconda D; Lichtiger S; Ullman T; Present DH; Kornbluth A Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1112-6. PubMed ID: 18928936 [TBL] [Abstract][Full Text] [Related]
11. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Nachury M; Moreau J; Delchier JC; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Dupas JL; Carbonnel F; Bommelaer G; Coffin B; Roblin X; Van Assche G; Esteve M; Färkkilä M; Gisbert JP; Marteau P; Nahon S; de Vos M; Franchimont D; Mary JY; Colombel JF; Lémann M; Lancet; 2012 Dec; 380(9857):1909-15. PubMed ID: 23063316 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab. Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Vuitton L; Moreau J; Amiot A; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Fumery M; Carbonnel F; Bommelaer G; Coffin B; Roblin X; van Assche G; Esteve M; Farkkila M; Gisbert JP; Marteau P; Nahon S; de Vos M; Lambert J; Mary JY; Louis E; Gut; 2018 Feb; 67(2):237-243. PubMed ID: 28053054 [TBL] [Abstract][Full Text] [Related]
13. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study. Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227 [TBL] [Abstract][Full Text] [Related]
14. Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis? Eun CS; Han DS Gut Liver; 2015 Sep; 9(5):567-8. PubMed ID: 26343066 [No Abstract] [Full Text] [Related]
15. Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study. Kim EH; Kim DH; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH Gut Liver; 2015 Sep; 9(5):601-6. PubMed ID: 25473080 [TBL] [Abstract][Full Text] [Related]
16. Infliximab for the treatment of acute exacerbations of ulcerative colitis. Bryan S; Andronis L; Hyde C; Connock M; Fry-Smith A; Wang D Health Technol Assess; 2010 May; 14 Suppl 1():9-15. PubMed ID: 20507798 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A for induction of remission in severe ulcerative colitis. Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937 [TBL] [Abstract][Full Text] [Related]
18. Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis. Ungar B; Mazor Y; Weisshof R; Yanai H; Ron Y; Goren I; Waizbard A; Yavzori M; Fudim E; Picard O; Loebstein R; Kopylov U; Dotan I; Chowers Y; Eliakim R; Ben-Horin S Aliment Pharmacol Ther; 2016 Jun; 43(12):1293-9. PubMed ID: 27091119 [TBL] [Abstract][Full Text] [Related]
19. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review. Thorne K; Alrubaiy L; Akbari A; Samuel DG; Morrison-Rees S; Roberts SE Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):369-82. PubMed ID: 26825217 [TBL] [Abstract][Full Text] [Related]
20. Commentary: salvage medical therapy for acute severe colitis - ciclosporin or infliximab? Sprakes MB; Hamlin PJ Aliment Pharmacol Ther; 2013 Oct; 38(8):988. PubMed ID: 24074307 [No Abstract] [Full Text] [Related] [Next] [New Search]